Pharmaceutical Business Method for High Volume Low Risk Sales

Abstract

A business method for pharmaceutical sales in which a single or multiple additional parties are introduced into the transaction such that a push market strategy results for the sales of pharmaceutical which are currently sold under patent licensing. The method promotes the widespread adoption of patented pharmaceuticals while reducing risk and increasing sales volume through guaranteed long term bulk purchase agreements. The resulting method lowers initial consumer prices of pharmaceuticals during the onset of early phase production while leveling prices toward the final phase of patent life.

What is claimed is: 
     
         1 . A method for high volume and low risk pharmaceutical sales; wherein a push market strategy, versus the standard pull market strategy, is achieved. 
     
     
         2 . The method of  claim 1  wherein one or more additional parties or entities negotiate a pull market strategy. 
     
     
         3 . The method of  claim 2  wherein a bulk purchase agreement is negotiated by said one or more additional parties or entities. 
     
     
         4 . The method of  claim 3  wherein the said bulk purchase agreement is enacted.